Skip to content

Validation of a non-invasive measured surrogate parameter for craniospinal compliance by measuring the electrical capacity of the head

Validation of a non-invasive measured surrogate parameter for craniospinal compliance by measuring the electrical capacity of the head - NiDCeC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022513
Enrollment
180
Registered
2020-07-27
Start date
2023-10-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G91.0 G97.0

Interventions

Group 1: Patients with cerebrospinal fluid circulation disorder. Measurement of the so-called Respiratory Amplitude Quotient (RAQ) in a seated and supine position Group 2: Patients without cerebrospin

Sponsors

Uniklinik Freiburg - Klinik für Neurochirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Suspicion of the presence of a liquor circulation disturbance.

Exclusion criteria

Exclusion criteria: Plaster allergy (possible skin irritation caused by the electrodes), and patients unable to give consent.

Design outcomes

Primary

MeasureTime frame
Respiratory Amplitude Coefficient (RAQ)

Secondary

MeasureTime frame
clinical parameters of gait disorders, spatial impairment, cognitive abilities, urinary incontinence, pain caused by headache, visual acuity, parameters of the computerized lumbar infusion test (baseline CSF pressure, pressure-volume index, pulse amplitude), documented intracranial pressures, cell count and total protein in CSF, diameter of the sonographic optic nerve sheath (ONSD), radiological findings. Age and sex of study participants, BMI, height, presence of comorbidities based on the Charlson comorbidity index (CCI) previous cranial operations, presence of cranial implants. The parameters are collected at the initial examination and, in patients with CSF circulation disorders, at follow-up examinations (always after 3 months).

Countries

Germany

Contacts

Public ContactMukesch Johannes Shah

Klinik für Neurochirurgie Uniklinik Freiburg

mukesch.shah@uniklinik-freiburg.de0761 27050010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026